Available Studentships
Please note that the deadline for applications was 7th December 2007. Successful applicants should be available for interview in the week commencing 28th January 2008.
Please register your interest with our online feedback form if you would like us to contact you should we have any similar opportunities available at a later date.
Please indicate which scientific disciplines (Biology, Chemistry, Physics & Engineering, Mechanism-based drug discovery) you are interested in.
|
|
|
Biological Sciences |
Chemistry |
|
|
|
| Physics & Engineering |
Mechanism-based Drug Discovery |
Funding
Studentships funded by The Institute of Cancer Research, Cancer Research UK, MRC or EPSRC will be supported for four years. The non-taxable stipend, which for 2007/08 is £18,000 (inner London - Chester Beatty Laboratories, Fulham Road) or £16,750 (outer London - Sutton Campus), is increased annually in-line with the increase to cost-of-living. Rates for 2008/09 will be published in May 2008.The Institute also offers Marie Curie-funded Studentships and Wellcome Trust-funded Studentships. These studentships have special eligibility requirements and stipend arrangements, and are marked with an asterisk (*) in the list below.
Find below a complete list of Institute studentships:
A novel, 3D protein kinase inhibitor library based on azacycles and azabicycles
Dr Ian Collins
New structural templates for kinase inhibition*
Professor Keith Jones and Dr Richard Bayliss
The role of lysyl oxidase in colorectal metastasis
Dr Janine Erler
Structural studies of human tripeptidyl peptidase II
Dr Edward Morris
Identification of aneuploidy predisposition genes
Professor Nazneen Rahman
The role of beta-catenin in prostate development and function
Dr Amanda Swain
Structural characterisation of MLL interactions
Dr Jon Wilson
Stromal fibroblasts in breast cancer
Professor Clare Isacke
Characterisation of the tumour suppressor menin and its role in the MLL chromatin regulation complex
Dr Jon Wilson
Targeting protein-protein interactions with drug-like azaspirocyclic scaffolds
Professor Keith Jones
Structural basis for PCNA regulation by monoubiquitylation
Professor Laurence Pearl
MicroRNAs involved in myogenesis and childhood tumours resembling skeletal muscle development
Dr Janet Shipley
Design and synthesis of fragment scaffolds enabled for rapid iterative follow up by parallel flow chemistry techniques
Professor Julian Blagg
Impact of carcinogens on causing mutational inactivation of the p53 gene in human tumours
Professor David Phillips
Acoustic and thermal characterisation of tissue properties for trans-costal HIFU treatment planning
Dr Gail ter Haar
Multiscale modelling of tumour evolution, diagnosis, prognosis and therapy in breast cancer
Drs Dimitra Darambara and Marketa Zvelebil
Histone methyltransferase Prmt1 in normal development and cancer therapeutics*
Drs Eric So and Jon Wilson
Genes involved in sensitivity to PI3 kinase inhibitors
Professor Paul Workman
PI3-kinase inhibitors that destabilise Mycn-mechanistic and pre-clinical evaluation using novel murine transgenic models of neuroblastoma
Dr Louis Chesler
Mechanism and significance of conformation-selective ligand-binding by the retinoblastoma protein
Dr Sibylle Mittnacht
Synthesis of lymphostin, a kinase inhibiting natural product and kinase targeted libraries derived from the lymphostin core
Dr Swen Hoelder
Integration, application and development of biophysical techniques in structure based drug discovery*
Professor Julian Blagg and Dr Rob van Montfort
Targeted disruption of TPR-domain recruitment to the Hsp90/Hsp70 molecular chaperone systems*
Professors Laurence Pearl and Paul Workman
Micro-scale tissue stiffness imaging for studying the interaction between matrix stiffness and cell signalling and motility
Dr Jeff Bamber
Radiation force elastography and optoacoustic imaging for assisting cancer detection and treatment
Dr Jeff Bamber
